Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene.

MLA

Suzanne M. Verwijnen, et al. “Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene.” Cancer Biotherapy & Radiopharmaceuticals, vol. 19, no. 1, Feb. 2004, pp. 111–20. EBSCOhost, https://doi.org/10.1089/108497804773391757.

APA

Suzanne M. Verwijnen, Peter A. E. Sillevis Smith, Rob C. Hoeben, Martin J. W. E. Rabelink, Leonard Wiebe, David T. Curiel, Akseli Hemminki, Eric P. Krenning, & Marion de Jong. (2004). Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene. Cancer Biotherapy & Radiopharmaceuticals, 19(1), 111–120. https://doi.org/10.1089/108497804773391757

Chicago

Suzanne M. Verwijnen, Peter A. E. Sillevis Smith, Rob C. Hoeben, Martin J. W. E. Rabelink, Leonard Wiebe, David T. Curiel, Akseli Hemminki, Eric P. Krenning, and Marion de Jong. 2004. “Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene.” Cancer Biotherapy & Radiopharmaceuticals 19 (1): 111–20. doi:10.1089/108497804773391757.